Presentations:     K=Keynote (20 min)     O=Oral (10 min)          PO=Poster-Oral (3 min)
 

07:30	Registration
08:30	Welcome
08:40	Session 1		Fetal growth and neonatal outcome
K	Irene Cetin	IT	Maternal & environmental factors
K	Karel Marsal	SE	Neurodevelopmental outcome after early onset FGR
O	Anouk Pels	NL	Neurodevelopmental outcomes at five years after early-onset FGR, analyses in a Dutch subgroup participating in a European management trial
O	Maria F Paz y Mino	ES	Severe fetal-growth restriction and normal doppler: neurodevelopmental evaluation at 54 months of age
K	Enrico Bertino	IT	Standards for neonatal size and catch up growth
O	Daniela Di Martino	IT	Prenatal assessment of IUGR versus postnatal diagnosis of SGA based on newborns weight charts: a muliticentre study
	Discussion
10:20	Refreshment Break
10:40	Session 2		Standards for fetal growth
K	Tullia Todros	IT	INTERGROWTH 21st
K	Torvid Kiserud	NO	The WHO fetal growth standard
K	Katherine Grantz	US	The NICHD program on fetal growth
K	Jason Gardosi	UK	Customised GROW charts
O	Tina Lavin	AU	Concordance between Intergrowth-21st and South African fetal growth standards for identfication of SGA in stillbirths
O	Oliver Hugh	UK	The effect of mixed parentage on ethnic variation in birthweight
12:20	Discussion
12:30	Lunch
13:15	Session 3		Poster-Oral 1    List
14:00	Session 4		Risk factors, Screening and Prevention
K	Patrizia Vergani	IT	Stillbirth and fetal growth
O	Paola D'Aloja	IT	Perinatal mortality surveillance: a pilot project in three Italian regions
O	Sara Ornaghi	IT	Use of customized curves for estimation of fetal weight and identification of late onset FGR at risk of adverse outcomes
K	Lesley McCowan	NZ	Risk assessment and prevention
O	Joyce Cowan	NZ	The Growth Assessment Protocol (GAP): New Zealand experience
O	Lynn Sadler	NZ	A reduction in perinatal mortality in New Zealand from 2008 to 2016 among small for gestational babies by customised birthweight centile
O	Mandy Williams	UK	Reduction in SGA stillbirths in England
15:30	Discussion
15:50	Refreshment Break
16:10	Session 5		Surveillance strategies for detection of growth restriction and macrosomia
O	Isabelle Monier	FR	Comparison of the Hadlock and Intergrowth 21st formulas for calculating estimated fetal weight among preterm infants: a population cohort study in France
O	Raigam J Martinez-Portilla	ES	Performance of third trimester ultrasound for the prediction of smallness-for-gestational age: a diagnostic test accuracy meta-analysis
O	Diletta Fumagalli	IT	Perinatal outcome of term fetuses born <10th centile: are small for gestational age and growth restricted fetuses different?
O	Jens Henrichs, Viki Verfaille	NL	Effectiveness and cost-effectiveness of routine third trimester ultrasound screening: the IUGR risk selection study (IRIS)
PO	Francesco D'Ambrosi	IT	Combined sequential ultrasound screening at 29 – 32 weeks and 35 – 37 weeks in detection of SGA fetuses
PO	Francesco D'Ambrosi	IT	Screening for small for gestational age fetuses with universal ultrasonography between 35 – 37 weeks in singleton low risk pregnancies: a prospective cohort study
PO	Andrew Sharp	UK	The current management of the small for gestational age fetus in the UK: A survey of practice
O	Gráinne Milne	IE	GAP: How is it working for us?
O	Susan Turner	UK	GAP SCORE: audit and analysis of SGA babies missed during antenatal surveillance
O	Andrea Dall'Asta	IT	Identification of large-for-gestational age fetuses using antenatal customized fetal growth charts: can we improve the prediction of abnormal labor course?
O	Lauren Jade Ewington	UK	Accuracy of antenatal ultrasound in predicting large-for-gestational age fetuses
O	Tracy Tomlinson	US	Validation of a prediction model for fetal overgrowth in pregnancies complicated by diabetes
17:50	Discussion
18:00	Close
20:00	Gala Dinner and Dance

                       
    Presentations:     K=Keynote (20 min)     O=Oral (10 min)     SO=Short Oral (5 min)     PO=Poster-Oral (3 min)
 

08:30	Session 6		Fetal growth restriction - early onset
K	Ahmet Baschat	US	Diagnosis and management of placenta based FGR <32 weeks
K	Enrico Ferrazzi	IT	Haemodynamics in pregnancies with growth restricted fetuses
O	Damiano Lo Presti	IT	Role of maternal haemodynamic evaluation in the definition of fetuses with growth restriction outcome
O	Manel Mendoza	ES	Pravastatin to treat early-onset fetal growth restriction
O	Jana Brodszki	SE	Management of very early onset IUGR. Single center experience 1998-2015
O	Tamara Stampalija	IT	Uterine arteries blood flow volume in fetuses with inappropriate growth for gestational age and normal doppler velocimetry
O	Andrew Sharp	UK	A prediction model for short-term neonatal outcomes in severe early-onset IUGR
	Discussion
10:10	Refreshment Break
10.30	Session 7		Fetal growth restriction - late onset
K	Francesc Figueras	ES	Investigation and management of late onset FGR
PO	M Serra	ES	Placental findings in small for gestational age and growth restricted fetuses
O	Marek Lubusky	CZ	Maternal serum levels of PlGF and sFlt-1 in predicting delivery of an SGA newborn
PO	Valentina Giardini	IT	Placental growth factor (plGF) as a marker of fetal growth restriction (FGR) caused by placental dysfunction: correlation with uterine arteries doppler and placental histology
PO	Federica Fusè	IT	sFlt-1/PlGF ratio in pregnancies complicated by placental insufficiency
PO	Federica Fusè	IT	sFlt-1/PlGF ratio and maternal hemodynamics in pregnancies complicated by placental insufficiency
PO	Serena Rigano	IT	The no man’s land between late IUGR and AGA fetuses: the constitutionally small fetus.
PO	Raigam J Martinez-Portilla	ES	Higher-risk of adverse perinatal outcome in adequate-for-gestational age fetuses with abnormal cerebro-placental ratio
PO	José Morales Rosello	ES	Comparison among cerebroplacental ratio, Intergrowth-21st standards, customized growth and local population references for the prediction of fetal compromise. Which is the best approach?
PO	José Morales Rosello	ES	Is it possible to predict late antepartum stillbirth by means of cerebroplacental ratio and maternal characteristics?
PO	Alice Zavatta	IT	Is labour induction the right choice in term IUGR fetuses?
PO	Eva Meler	ES	Perinatal outcomes when electively inducing low fetal weight
	Discussion
11:30	Session 8		Fetal Growth in Twins
O	Tullio Ghi	IT	The Italian multicentre study
O	Katherine Grantz	US	The NICHD fetal growth studies on dichorionic twin pairs
PO	Mariano Lanna	IT	Twin-specific doppler nomograms in uncomplicated monochorionic twins
	Discussion
PO	Carman Wing Sze Lai	HK	Perinatal outcomes among twin with severe growth discordance more than 30% in a 7-year retrospective cohort
PO	Mariano Lanna	IT	Monochorionic twin pregnancies complicated with twin-twin transfusion syndrome and selective growth restriction of donor twin
PO	Mariano Lanna	IT	Perinatal outcome in monochorionic twin pregnancies complicated with selective intrauterine growth restriction
12:15	Lunch
13:00	Session 9		Poster-Oral 2    List
14:00	Session 10		Therapies for placental insufficiency - The EVERREST Studies
O	Anna David	UK	Scientific rationale and aims of the consortium
O	Rebecca Spencer	UK	Ethical issues in a trial of maternal gene therapy
			Understanding early onset FGR: The EVERREST Prospective study
SO	Kasia Maksym	UK	Outcomes of early onset FGR: the fetus
SO	Francesc Figueras	ES	Early onset FGR - baseline medical and obstetric characteristics: 6 year prospective study
SO	Ingran Lingam	UK	Outcomes of early onset FGR: the neonate at 12 months
SO	Anna David	UK	Pregnant women’s experiences and perceptions of study participation
O	Karel Marsal	SE	Challenges in recruitment in studies of FGR
SO	Tommi Heikura	FI	Reproductive toxicology studies: human placenta and pre-clinical rabbit
	Discussion
			Developing and Planning the EVERREST clinical trial
SO	Tommi Heikura	FI	Developing the ATIMP (Advanced Therapy Investigational Medicinal Product) for EVERREST
SO	Robert Shaw	UK	Manufacturing the EVERREST IMP (Investigational Medicinal Product)
SO	Anna David	UK	FGR as an orphan disease
SO	Rebecca Spencer	UK	Inclusion and exclusion criteria and predicting outcome of early onset FGR
SO	Rebecca Spencer	UK	Developing standard maternal and fetal adverse event criteria for FGR clinical trials
SO	Jade Dyer	UK	Regulatory Process - MHRA
	Discussion; Closing Remarks
15:50	Refreshment Break
16:10	Session 11		Debate: Are we placing too much emphasis on fetal size?
O	Wessel Ganzevoort	NL	Yes; let's get away from dichotomisation
O	Jason Gardosi	UK	No; size does matter when assessing growth
16:30	Discussion
16:45	Session 12		Policies & Protocols: do they reflect the evidence
K	Lesley McCowan	NZ	Overview of international guidelines on fetal growth
O	Patrizia Vergani	IT	Protocols in Lombardy and Italy
17:15	Plenary / Open Forum		General discussion and take home messages
17:45	Best abstracts		Awards & Presentations
18:00	Close

                       
     PO=Poster-Oral Presentation (3 min)
 

Tue 13:15	Session 3		Poster-Oral 1
PO 3.1	Fida Ali	UK	Are our SGA babies slipping through the net?
PO 3.2	JM Arraez	ES	Screening programme for fetal growth restriction in low risk population
PO 3.3	Sima Delavari	UK	To evaluate GROW customised charts in the classification of term birthweight infants <2.5kg and their predictive value for neonatal care unit admission
PO 3.4	Sabrina Demirdjian	AR	Perinatal outcome and morbidity in small for gestational age newborns with and without prenatal diagnosis
PO 3.5	Nandini Halder	UK	Retrospective analysis of small for gestational age (SGA) babies at our health board following implementation of the growth assessment protocol (GAP)
PO 3.6	Ditte Nymark Hansen	DK	Screening for small-for-gestational-age fetuses in Denmark
PO 3.7	Graham Tydeman	UK	The rising number of growth scans and an audit of screening for SGA in women with a low PAPP-A
PO 3.8	Andrea Dall'Asta	IT	Accuracy of the symphysis-fundal height as a screening test for small-for-gestational age fetuses at birth within a low risk population
PO 3.9	Andrea Dall'Asta	IT	Prediction of small for gestational age neonates and adverse outcomes in late onset fetal growth restriction: a comparison of standard and Intergrowth charts
PO 3.10	Anna Carli	IT	Identification of fetal growth restriction in a population of stillbirths: a comparison of three different growth curves
PO 3.11	Oliver Hugh	UK	Stillbirth risk and SGA rate in subgroups according to maternal size: comparison of GROW, WHO and IG21 fetal growth standards
PO 3.12	Lesley McCowan	NZ	The effect of maternal going-to-sleep position on birthweight: a secondary analysis of an individual participant data meta-analysis of going-to-sleep position and the risk of late stillbirth
Wed 13:00	Session 9		Poster-Oral 2
PO 9.1	Irene Beune	NL	Definitions of fetal growth restriction in existing literature over time: A systematic review
PO 9.2	Irene Beune	NL	Consensus based definitions of fetal growth restriction
PO 9.3	Sabrina Demirdjian	AR	Subtle cardiovascular changes in small for gestational age fetuses may be associated with neonatal morbidity
PO 9.4	V Priyadarshini	IN	Cardiac function and doppler indices before and after administration of steroid in fetuses with growth restriction
PO 9.5	Grazia Tiralongo	IT	A Pilot study of fetal growth, maternal hemodynamics and plasma and placental expression of epidermal growth factor
PO 9.6	Josephine Luppino	IT	Physiopathology of adrenal sparing: ultrasound and functional evaluation of foetal adrenal glands in relation to foetal growth restriction and pre-eclampsia
PO 9.7	Clara Bruin	NL	Inter- and Intra-observer variability in ductus venosus blood flow measurement
PO 9.8	Megan Sharps	UK	Elevated numbers of placental macrophages in pregnancies complicated with fetal growth restriction
PO 9.9	Tamara Stampalija	IT	Umbilical vein blood flow volume in fetuses with inappropriate growth for gestational age and normal doppler velocimetry
PO 9.10	Tamara Stampalija	IT	Uterine and umbilical vein blood flow volume in fetuses detected antenatally as inappropriate for gestational age but with normal birthweight
PO 9.11	Caterina Neri	IT	Fetal dopplers at term in pregnancies affected by gestational diabetes: role in prediction of perinatal outcomes
PO 9.12	Marta Rial-Crestelo	ES	Evaluation of the quality and reliability of middle cerebral artery (MCA) and umbilical artery (UA) doppler images in a randomized controlled trial
PO 9.13	Maddy Smies	NL	Birthweight/placenta weight ratio in clinically unexpected stillbirth
PO 9.15	Sanne Gordijn	NL	Free thiols in maternal serum and urine for the detection of fetal growth restriction

                       
    Electronic posters will be on display throughout the conference
 

	Author		Title
P 1	Gerard Albaigés	ES	Early growth velocity and mode of conception in the prediction of small for gestational age (SGA)
P 2	Ezra Aydin	UK	Anogenital distance in male and female fetuses at 26 to 30 weeks gestation
P 4	Clara Bruin	NL	A study of STV calculation algorithms – comparison of two applications for computerized CTG analysis
P 5	Ricardo Ciammella	AR	Is low cerebro placental ratio (CPR), as a placental disfunction marker, a limitant to reach the optimal weight in dichorionic pregnancies?
P 6	Magdalena Zgliczynska	PL	Partial molar pregnancy coexisting with a live diploid fetus, complicated by intrauterine growth restriction and eclampsia
P 7	Magdalena Zgliczynska	PL	The association between expression of microrna-21 and microrna-141 with the occurrence of intrauterine growth restriction
P 8	Edel Clare	UK	Fundal height measurements - size does matter
P 9	Alex Collister	UK	Clinical evaluation of the effectiveness of low PAPP-A in the identification of small-for-gestional-age babies: A GDH audit
P 10	Joyce Cowan	NZ	Fundal height measurement accuracy pre-and post training
P 11	Aseela Dassanayake	UK	Audit: Was there adequate utilisation of the customised growth chart and its principles in the detection of all growth restricted babies below the 10th centile, delivered in a small DGH
P 12	Anna Kajdy	PL	Is it better to be big or small? - Adverse perinatal outcomes comparison
P 13	Ryan Lavery	UK	Accuracy of antenatal ultrasound estimation of fetal weight within South-Eastern Health & Social Care Trust (SEHSCT)
P 14	Rebecca Lawes	UK	Student midwives' perception of the growth assessment protocol (GAP): Preparation for clinical practice
P 15	Flurina Michelotti	UK	Accuracy of fetal weight by ultrasound
P 16	Hannah Mistry	UK	Identification and management of antenatal risk factors for growth restricted babies in a district general hospital
P 18	Rachael O'Flaherty	UK	Experience of GROW programme in Causeway Hospital, Northern Ireland
P 19	C Perry	UK	Screening, detection and management of small for gestational age fetuses at the Liverpool Women’s Hospital
P 20	Mini Poothavelil	UK	Circumvallate placenta and early onset intrauterine growth restriction
P 21	Fadimatu Aliya Umaru	UK	A case of Non-Hodgkin's lymphoma in pregnancy
P 22	Radhika Viswanatha	UK	Outcome of large for gestational age fetus in an unselected population in non-diabetic mothers who delivered before 40 weeks’ gestation
P 23	Amira Younis	EG	Effect of diabetes mellitus in pregnancy on fetal liver length measurements
P 24	Stefano Faiola	IT	Longitudinal assessment of interventricular septum thickness in monochorionic biamniotic twins complicated by TTTS and treated with laser coagulation of placental anastomoses
P 25	Valentina Giardini	IT	A possible role of placental growth factor (PlGF) in the management of fetal growth restriction (FGR) with abnormal umbilical artery doppler velocimetry
P 26	Josephine Luppino	IT	Preterm infants outcomes: Is more important the weight or the gestational age?
P 27	Edurne Mazarico	ES	Birth weight and nutritional indices prediction using fractional limb volume and estimated fetal weight
P 28	Carlo Personeni	IT	Labour, maternal and neonatal outcomes in IUGR fetuses induced at term
P 29	Lynne Warrander	UK	Prediction of pregnancy outcome in extreme early-onset fetal growth restriction: An exploratory prognostic factor study
P 30	Heather Watson	UK	Treasure hunting: Establishing a Midwife-Led fetal growth assessment (MFGA) clinic to identify the high risk fetus in the low risk pregnancy
P 31	Noha Al-Okda	EG	Umbilical artery intima-media thickness: A predictor of poor perinatal outcome in fetal growth restriction